Schizophrenia

Measuring quality of life in patients with schizophrenia: an update.

Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics. 2012;30(3):183-95. DOI: 10.2165/11594470-000000000-00000. PubMed PMID: 22263841.

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.

Correll CU, Skuban A, Ouyang J, Hobart M, Pfister S, McQuade RD, et al. Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial. Am J Psychiatry. 2015;172(9):870-80. DOI: 10.1176/appi.ajp.2015.14101275. PubMed PMID: 25882325.

Sperm bank failed to reveal donor's criminal record and schizophrenia, couple alleges.

Dyer O. Sperm bank failed to reveal donor's criminal record and schizophrenia, couple alleges. BMJ. 2015;350:h2001. DOI: 10.1136/bmj.h2001. PubMed PMID: 25872510.

Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.

Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics. 2007;48(5):412-7. DOI: 10.1176/appi.psy.48.5.412. PubMed PMID: 17878500.

Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes.

Ogawa M, Miyamoto Y, Kawakami N. Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes. Arch Psychiatr Nurs. 2011;25(1):63-73. DOI: 10.1016/j.apnu.2010.06.002. PubMed PMID: 21251603.

The dietary pattern of patients with schizophrenia: a systematic review.

Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res. 2013;47(2):197-207. DOI: 10.1016/j.jpsychires.2012.10.005. PubMed PMID: 23153955.

Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.

Rajji TK, Mulsant BH, Davies S, Kalache SM, Tsoutsoulas C, Pollock BG, et al. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. Am J Psychiatry. 2015;172(6):579-85. DOI: 10.1176/appi.ajp.2015.14050673. PubMed PMID: 25859763.

Influences of schizophrenia risk variant rs7914558 at CNNM2 on brain structure.

Ohi K. Influences of schizophrenia risk variant rs7914558 at CNNM2 on brain structure. Br J Psychiatry. 2015;206(4):343-4. DOI: 10.1192/bjp.206.4.343b. PubMed PMID: 25833874.

Authors' reply.

Donohoe G, Rose E, Morris D. Authors' reply. Br J Psychiatry. 2015;206(4):344. DOI: 10.1192/bjp.206.4.344. PubMed PMID: 25833875.

The RAISE early treatment program for first-episode psychosis: background, rationale, and study design.

Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, et al. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry. 2015;76(3):240-6. DOI: 10.4088/JCP.14m09289. PubMed PMID: 25830446.